Literature DB >> 24320879

Low-oxygen culture conditions extend the multipotent properties of human retinal progenitor cells.

Petr Y Baranov1, Budd A Tucker, Michael J Young.   

Abstract

PURPOSE: Development of an effective cell-based therapy is highly dependent upon having a reproducible cell source suitable for transplantation. One potential source, isolated from the developing fetal neural retina, is the human retinal progenitor cell (hRPC). One limiting factor for the use of hRPCs is their in vitro expansion limit. As such, the aim of this study was to determine whether culturing hRPCs under 3% O2 would support their proliferative capacity while maintaining multipotency.
METHODS: To determine the effect of low oxygen on the ability of hRPCs to self-renew, rates of proliferation and apoptosis, telomerase activity, and expression of proliferative, stemness, and differentiation markers were assessed for hRPCs cultured in 3% and 20% oxygen conditions.
RESULTS: Culture under 3% oxygen increases the proliferation rate and shifts the proliferation limit of hRPCs to greater 40 divisions. This increased capacity for proliferation is correlated with an upregulation of Ki67, CyclinD1, and telomerase activity and a decrease in p53 expression and apoptosis. Increased expression of cMyc, Klf4, Oct4, and Sox2 in 3% O₂ is correlated with stabilization of both HIF1α and HIF2α. The eye field development markers Pax6, Sox2, and Otx2 are present in hRPCs up to passage 16 in 3% O₂ . Following in vitro differentiation hRPCs expanded in the 3% O₂ were able to generate specialized retinal cells, including rods and cones.
CONCLUSIONS: Low-oxygen culture conditions act to maintain both multipotency and self-renewal properties of hRPCs in vitro. The extended expansion limits permit the development of a clinical-grade reagent for transplantation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24320879      PMCID: PMC4251088          DOI: 10.1089/ten.TEA.2013.0361

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  78 in total

1.  HIF-1alpha and p53: the ODD couple?

Authors:  Diane R Fels; Constantinos Koumenis
Journal:  Trends Biochem Sci       Date:  2005-08       Impact factor: 13.807

Review 2.  Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degeneration.

Authors:  C Grimm; D M Hermann; A Bogdanova; S Hotop; U Kilic; A Wenzel; E Kilic; M Gassmann
Journal:  Semin Cell Dev Biol       Date:  2005-04-18       Impact factor: 7.727

3.  Low O2 tensions and the prevention of differentiation of hES cells.

Authors:  Toshihiko Ezashi; Padmalaya Das; R Michael Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-16       Impact factor: 11.205

4.  Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells.

Authors:  Victoria Wang; David A Davis; Muzammel Haque; L Eric Huang; Robert Yarchoan
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

Review 5.  Effects of hypoxia on the proliferation and differentiation of NSCs.

Authors:  Ling-Ling Zhu; Li-Ying Wu; David Tai Yew; Ming Fan
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

6.  Regulation of proliferation and photoreceptor differentiation in fetal human retinal cell cultures.

Authors:  M W Kelley; J K Turner; T A Reh
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-06       Impact factor: 4.799

7.  Cell cycle protein expression and proliferative status in human corneal cells.

Authors:  N C Joyce; B Meklir; S J Joyce; J D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-03       Impact factor: 4.799

8.  Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha.

Authors:  W G An; M Kanekal; M C Simon; E Maltepe; M V Blagosklonny; L M Neckers
Journal:  Nature       Date:  1998-03-26       Impact factor: 49.962

9.  Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis.

Authors:  P Carmeliet; Y Dor; J M Herbert; D Fukumura; K Brusselmans; M Dewerchin; M Neeman; F Bono; R Abramovitch; P Maxwell; C J Koch; P Ratcliffe; L Moons; R K Jain; D Collen; E Keshert; E Keshet
Journal:  Nature       Date:  1998-07-30       Impact factor: 49.962

10.  Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene.

Authors:  C W Pugh; C C Tan; R W Jones; P J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more
  23 in total

1.  A Novel Neuroprotective Small Molecule for Glial Cell Derived Neurotrophic Factor Induction and Photoreceptor Rescue.

Authors:  Petr Baranov; Hong Lin; Kathryn McCabe; David Gale; Shenshen Cai; Burke Lieppman; Dwight Morrow; Phoebe Lei; Justin Liao; Michael Young
Journal:  J Ocul Pharmacol Ther       Date:  2017-04-25       Impact factor: 2.671

Review 2.  Stem cell therapy for retinal diseases.

Authors:  José Mauricio Garcia; Luisa Mendonça; Rodrigo Brant; Murilo Abud; Caio Regatieri; Bruno Diniz
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

3.  Enhanced differentiation and delivery of mouse retinal progenitor cells using a micropatterned biodegradable thin-film polycaprolactone scaffold.

Authors:  Jing Yao; Chi Wan Ko; Petr Y Baranov; Caio V Regatieri; Stephen Redenti; Budd A Tucker; Jason Mighty; Sarah L Tao; Michael J Young
Journal:  Tissue Eng Part A       Date:  2015-03-19       Impact factor: 3.845

4.  [Effects of leptin on proliferation and differentiation of hypoxic rat retinal progenitor cells in vitro].

Authors:  Y Xing; Z Liu; X Zhang; J Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-03-20

Review 5.  Use of human pluripotent stem cells to study and treat retinopathies.

Authors:  Karim Ben M'Barek; Florian Regent; Christelle Monville
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 6.  Retinal stem cell transplantation: Balancing safety and potential.

Authors:  Mandeep S Singh; Susanna S Park; Thomas A Albini; M Valeria Canto-Soler; Henry Klassen; Robert E MacLaren; Masayo Takahashi; Aaron Nagiel; Steven D Schwartz; Kapil Bharti
Journal:  Prog Retin Eye Res       Date:  2019-09-05       Impact factor: 21.198

7.  Low-oxygen and knock-out serum maintain stemness in human retinal progenitor cells.

Authors:  Deepti Singh; Pierre C Dromel; Michael Young
Journal:  Mol Biol Rep       Date:  2020-01-16       Impact factor: 2.316

Review 8.  Regenerating Eye Tissues to Preserve and Restore Vision.

Authors:  Jeffrey H Stern; Yangzi Tian; James Funderburgh; Graziella Pellegrini; Kang Zhang; Jeffrey L Goldberg; Robin R Ali; Michael Young; Yubing Xie; Sally Temple
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

9.  The Effect of Transient Local Anti-inflammatory Treatment on the Survival of Pig Retinal Progenitor Cell Allotransplants.

Authors:  Murilo Abud; Petr Baranov; Caroline Hicks; Sara Patel; Burke Lieppman; Caio Regatieri; John Sinden; David Isaac; Marcos Avila; Michael Young
Journal:  Transl Vis Sci Technol       Date:  2015-09-22       Impact factor: 3.283

10.  VSX2 and ASCL1 Are Indicators of Neurogenic Competence in Human Retinal Progenitor Cultures.

Authors:  Lynda S Wright; Isabel Pinilla; Jishnu Saha; Joshua M Clermont; Jessica S Lien; Katarzyna D Borys; Elizabeth E Capowski; M Joseph Phillips; David M Gamm
Journal:  PLoS One       Date:  2015-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.